Shares of Pfizer (NYSE: PFE) have been stuck in the mud since December 2022, with its shares down more than 45% over that ...

Pfizer is looking to use AI in a Singapore initiative to shorten the drug discovery process. Read more at straitstimes.com.

“It might start becoming the top circulating lineage,” Rajnaranayam said, predicting XEC will take the rest of October and ...

The EU's second-highest court, the General Court of the European Union, ruled partially against the Commission’s decision to ...

London: Pfizer recently achieved a significant legal victory by winning bid in a London court to invalidate two patents held ...